United States: When An Overpayment Becomes A False Claims Act Issue: Explaining The First Judicial Interpretation Of The 60-Day Rule

On August 3, 2015, Judge Edgardo Ramos of the United States District Court for the Southern District of New York issued the first judicial opinion addressing when a health care provider has "identified" a Medicare or Medicaid overpayment under the Affordable Care Act's (ACA) requirement that providers return overpayments within sixty days of the date the payment is identified (the "60-Day Rule") or face potential liability under the federal False Claims Act (FCA). In United States ex rel. Kane v. Continuum Health Partners, Inc., No. 11-2325 (S.D.N.Y. Aug. 3, 2015), the court concluded that "the sixty day clock begins ticking when a provider is put on notice of a potential overpayment, rather than the moment when an overpayment is conclusively ascertained."1

60-Day Rule

Section 6402(a) of the ACA requires providers, suppliers, Medicare Advantage organizations, prescription drug plan sponsors, and Medicaid managed care organizations to "report and return" an "overpayment" within the later of (a) sixty days after the overpayment is "identified," or (b) the date any corresponding cost report is due, if applicable. The 60-Day Rule defines an "overpayment" as any funds a person receives or retains under Medicare or Medicaid to which the person, after applicable reconciliation, is not entitled. Congress left the term "identified" undefined. On February 16, 2012, the Centers for Medicare and Medicaid Services (CMS) issued a notice of proposed rulemaking to implement the 60-Day Rule for Medicare Parts A and B. In the notice, CMS proposed to define "identified" as the time a person has "actual knowledge of the existence of the overpayment or acts in reckless disregard or deliberate ignorance of the existence of the overpayment."2 It also proposed that, when a provider receives information about a "potential" overpayment, there is an obligation "to make a reasonable inquiry" to determine whether an overpayment exists. Failure to make such an inquiry "with all deliberate speed" could result in the provider knowingly retaining an overpayment. CMS has delayed its deadline to publish the final rule until February 2016, and in the meantime, healthcare providers continue to wrestle with when their sixty days for repayment begin.3

If a provider misses the sixty-day-repayment window, it could face treble damages and statutory penalties under the FCA. Under the ACA, an overpayment retained after the deadline is an "obligation" under the False Claims Act.4 The FCA, as amended by the Fraud Enforcement and Recovery Act (FERA), provides liability for one who "knowingly conceals or knowingly and improperly avoids or decreases an obligation to pay or transmit money or property to the Government."5 The FCA defines "knowingly" to include both "actual knowledge" and situations where a provider "acts in deliberate ignorance" or "reckless disregard" of the truth or falsity of information.6

Factual Background

In Continuum, whistleblower Robert P. Kane alleged that three New York City hospitals belonging to a network of non-profit hospitals operated by Continuum Health Partners, Inc. (Continuum) violated the FCA by failing to repay identified overpayments within sixty days. Following a civil investigation, both the United States Attorney's Office for the Southern District of New York and the State of New York (collectively the "Government") intervened. The Government's claims arose from services provided by each of the hospitals to Medicaid patients who were members of a managed care program administered by Healthfirst, Inc., a non-profit insurance company. The Continuum hospitals contractually agreed to accept reimbursement only from Healthfirst for certain covered services. A software glitch, however, caused the hospitals mistakenly to seek additional secondary payment from other payors, including Medicaid. As a result, the New York State Department of Health (DOH) incorrectly made secondary payment for claims submitted by the hospitals in 2009.

In September 2010, auditors from the New York State Comptroller's office approached Continuum with questions about the incorrect billings. Between September 2010 and December 2010, the parties uncovered the software glitch and a corrective software patch was implemented. Thereafter, Kane, a Continuum employee, was asked to determine which claims were improperly submitted to Medicaid. Kane reviewed the claims between late 2010 and early 2011, and on February 4, 2011, he sent an email to several members of Continuum's management with a spreadsheet listing more than 900 claims (totaling over $1 million) that Kane believed were incorrectly billed.7 Kane's email also indicated that further analysis would be needed to confirm his findings. Independently, the New York Comptroller alerted Continuum of approximately five additional claims for which Medicaid was incorrectly billed.

Four days after Kane sent his email, he was terminated. Sixty-one days after Kane sent his email, he filed a qui tam complaint under seal alleging violations of the FCA. Although Continuum repaid the first five improper claims identified by the Comptroller in February 2011, the Government alleged that Continuum "did nothing further" with Kane's analysis and "never brought Kane's analysis to the attention of the Comptroller despite many communications with the Comptroller concerning additional claims to be repaid." Unrelated to Kane's analysis, the Comptroller independently identified several additional batches of improper claims between March 2011 and February 2012. Although Continuum began to repay those claims identified by the Comptroller in April 2011, the Government alleged that Continuum did not complete its repayment until March 2013. In particular, the district court noted that it was not until the Government issued a civil investigative demand seeking additional information about the overpayments in June 2012 (over a year after Kane's email), that Continuum finally reimbursed the DOH for more than 300 overpayments.

Court's Ruling

In denying the Defendants' motion to dismiss the Government's complaints in intervention, the Southern District of New York agreed with the Government that the whistleblower's email and spreadsheet "identified" overpayments within the meaning of the ACA, and that these overpayments matured into "obligations" in violation of the FCA when they were not reported and returned by Defendants within sixty days. The court employed theories of statutory interpretation and reviewed the legislative history and purpose of the ACA, FCA, and FERA to determine that an overpayment is "identified" when the provider "is put on notice of a potential overpayment, rather than the moment when an overpayment is conclusively ascertained."8 Judge Ramos reasoned that this duty to repay may arise "even if the precise amount due has yet to be determined.9 Despite Continuum's argument that Kane's email only provided "notice of potential overpayments and did not identify actual overpayments,"10 the court held that such an email must constitute an identification, or otherwise the Government would have no recourse when a provider "simply ignor[es] the analysis altogether and put[s] its head in the sand."11

Recognizing that the court's ruling imposes "a demanding standard of compliance" and "a stringent—and, in certain cases, potentially unworkable—burden on providers," the court noted that even where an "obligation" arises to repay money, a violation of the FCA also requires that the obligation be "knowingly concealed or knowingly and improperly avoided or decreased."12 This suggests that providers may avoid incurring FCA liability even beyond the sixty-day window if they can show that they have not concealed, avoided, or decreased their obligation to repay. The court further noted that "prosecutorial discretion would counsel against the institution of enforcement actions aimed at well-intentioned healthcare providers working with reasonable haste to address erroneous overpayments.13 Notably, the court suggested that its reasoning was consistent with CMS's proposed rule even though that rule has yet to be finalized.

Practical Implications

The Continuum decision provides insight into how at least one federal jurisdiction interprets the 60-Day Rule. While this ruling is technically binding only in the Southern District of New York, it is reasonable to expect that other courts will look to its reasoning for guidance. In addition, CMS may consider the case in defining when an overpayment is "identified" in its forthcoming final rule. In the meantime, healthcare providers should consider the following implications of the Continuum decision:

  • Once a healthcare provider is put on notice of a potential overpayment, the government may take the position that a provider must have qualified individuals diligently conduct a timely and good-faith investigation.
  • Healthcare providers should document their investigative efforts to demonstrate that they conducted a timely internal investigation.
  • Given the severe repercussions and swift deadlines of the 60-Day Rule, as interpreted in Continuum, healthcare providers should carefully consider which internal and outside personnel they ask to complete that investigation.
  • Healthcare providers may need to initiate the repayment process before knowing the exact amount of overpayment and should be prepared to explain their repayment analysis to the government when they do so.
  • While certain providers may benefit from prosecutorial discretion if they demonstrate diligent response efforts, such discretion is far from guaranteed and would be limited to those cases initiated by the Government.

A copy of the court's opinion is available here.


[1] Id. at 23 (emphasis added).

[2] 77 Fed. Reg. 9179-9187 (Feb. 16, 2012).

[3] CMS separately issued a final rule implementing the 60-Day Rule with respect to the Medicare Advantage program and the Medicare Part D Prescription Drug program. See 79 Fed. Reg. 29844 (May 23, 2014). In that final rule, CMS indicated that a Medicare Advantage organization or Part D sponsor has identified an overpayment "when the [entity] has determined, or should have determined through the exercise of reasonable diligence, that [it] has received an overpayment." 42 C.F.R. §§ 422.326(c), 423.360(c). While this final rule and CMS's commentary thereto were not at issue in the Continuum decision, the court did note that "its logic plainly does [apply]." Continuum at 30.

[4] 42 U.S.C. § 1320a-7k(d)(3).

[5] 31 U.S.C. § 3729(a)(1)(G).

[6] Id. § 3729(b)(1)(A).

[7] Although Kane's email overestimated how many claims were improperly billed to Medicaid, approximately half of the items listed did, in fact, constitute overpayments.

[8] Continuum at 33.

[9] Id. at 24.

[10] Id. at 17.

[11] Id. at 26.

[12] Id.

[13] Id.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

*** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.